Zepbound 12.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DX25F6SXP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $33,237
Award facts
- Contract value 100% obligated
- $33,236.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Zepbound (semaglutide) 12.5 mg/0.5 mL pen injections. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $33,236.84 and is scheduled for completion by August 7, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that provides comprehensive global pharmaceutical support to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is a critical federal vendor supplying an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's federal contract awards demonstrate consistent capability to meet Defense Logistics Agency procurement requirements through open competition on delivery orders with firm fixed pricing. This award for Zepbound, a diabetes and weight management medication, aligns with AmerisourceBergen's established role in supporting military healthcare systems, the Defense Health Agency, and other government healthcare entities through flexible contract vehicles designed to meet evolving pharmaceutical supply needs.
Quick answers
Who was awarded contract SPE2DX25F6SXP?
SPE2DX25F6SXP was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on August 6, 2025.
How much is contract SPE2DX25F6SXP worth?
The government has obligated $33,237 on SPE2DX25F6SXP.
Is contract SPE2DX25F6SXP an order under another contract?
Yes. SPE2DX25F6SXP is a delivery order under SPE2DX15D1053, an indefinite delivery contract.
Was contract SPE2DX25F6SXP competed?
The extent of competition for SPE2DX25F6SXP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award